Transurethral Use of Evicel(®) Fibrin Sealant.

Urol Case Rep

Masel Urology Center, 4030 Sheridan Street, Suite C, Hollywood, FL 33021, USA.

Published: January 2016

Transurethral resection of bladder tumor remains the most common procedure for the diagnosis, management, and treatment of bladder cancer. Deep resection of the detrusor muscle for the correct staging of bladder cancer can increase the risk of hemorrhage that can be difficult to control with standard transurethral surgical maneuvers. Evicel(®) Fibrin Sealant was applied transurethrally to manage difficult hemorrhage following transurethral resection of bladder tumor in two surgically complex bladder cancer patients. Our early experience suggests Evicel(®) can be an effective tool in managing difficult to control hemorrhage associated with TURBT. Further clinical investigation is to be encouraged.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719787PMC
http://dx.doi.org/10.1016/j.eucr.2015.10.006DOI Listing

Publication Analysis

Top Keywords

bladder cancer
12
evicel® fibrin
8
fibrin sealant
8
transurethral resection
8
resection bladder
8
bladder tumor
8
difficult control
8
bladder
5
transurethral
4
transurethral evicel®
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!